Microarray data - the USFDA, industry and academia

被引：28

作者：

Hackett, JL ^{[1
]}

Lesko, LJ

机构：

[1] US FDA, Off In Vitro Diagnost Device Evaluat & Safety, Ctr Devices & Radiol Hlth, Rockville, MD 20850 USA

[2] US FDA, Off Clin Pharmacol & Biopharmaceut, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA

来源：

NATURE BIOTECHNOLOGY | 2003年 / 21卷 / 07期

关键词：

D O I：

10.1038/nbt0703-742

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：742 / 743

页数：2

共 2 条

[1] Pharmacogenetics and pharmacogenomics in drug development and regulatory decision making: Report of the first FDA-PWG-PhRMA-DruSafe workshop [J].

Lesko, LJ ;

Salerno, RA ;

Spear, BB ;

Anderson, DC ;

Anderson, T ;

Brazell, C ;

Collins, J ;

Dorner, A ;

Essayan, D ;

Gomez-Mancilla, B ;

Hackett, J ;

Huang, SM ;

Ide, S ;

Killinger, J ;

Leighton, J ;

Mansfield, E ;

Meyer, R ;

Ryan, SG ;

Schmith, V ;

Shaw, P ;

Sistare, F ;

Watson, M ;

Worobec, A .

JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (04) :342-358

[2] Medical applications of microarray technologies: a regulatory science perspective [J].

Petricoin, EF ;

Hackett, JL ;

Lesko, LJ ;

Puri, RK ;

Gutman, SI ;

Chumakov, K ;

Woodcock, J ;

Feigal, DW ;

Zoon, KC ;

Sistare, FD .

NATURE GENETICS, 2002, 32 (Suppl 4) :474-479

← 1 →